Cambium Bio (ASX:CMB) Price-to-Tangible-Book : (As of May. 05, 2025)

View and export this data going back to 2013. Start your Free Trial

What is Cambium Bio Price-to-Tangible-Book?

As of today (2025-05-05), Cambium Bio's share price is A$0.22. Cambium Bio's Tangible Book per Share of Dec. 2024 for the quarter that ended in Dec. 2024 was A$-0.06. Hence, Cambium Bio's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Cambium Bio's Price-to-Tangible-Book or its related term are showing as below:

During the past 11 years, Cambium Bio's highest Price to Tangible Book Ratio was 18.52. The lowest was 2.97. And the median was 7.03.

ASX:CMB's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.615
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Cambium Bio's share price is A$0.22. Cambium Bio's Book Value per Sharefor the quarter that ended in Dec. 2024 was A$0.13. Hence, Cambium Bio's P/B Ratio of today is 1.75.

Cambium Bio Price-to-Tangible-Book Historical Data

The historical data trend for Cambium Bio's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cambium Bio Price-to-Tangible-Book Chart

Cambium Bio Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Price-to-Tangible-Book

Get a 7-Day Free Trial

9.32

17.38

18.52

Cambium Bio Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	-	-	18.52	-

Competitive Comparison of Cambium Bio's Price-to-Tangible-Book

For the Biotechnology subindustry, Cambium Bio's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cambium Bio's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cambium Bio's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Cambium Bio's Price-to-Tangible-Book falls into.

Save Embed

;

Save Embed

;

Cambium Bio Price-to-Tangible-Book Calculation

Cambium Bio's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2024 )
	=	0.22	/	-0.058
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Cambium Bio Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Cambium Bio's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Cambium Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cambium Bio Ltd (ASX:CMB) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

16 Goodhope Street, Paddington, Sydney, NSW, AUS, 2021

Website

https://www.cambium.bio

Cambium Bio Ltd is a clinical-stage regenerative medicine company in Australia. It focuses on the development of biologics for ophthalmology and tissue repair applications. Its technology platform is based on human platelet lysate, which is being leveraged to create a pipeline of novel therapeutics, with a primary focus on ophthalmology. The company's product candidate Elate Ocular is being developed to address unmet medical needs in the treatment of dry eye disease. In addition, its stem cell platform, Progenza, is being applied to the development of therapies for knee osteoarthritis and other tissue repair indications.

Cambium Bio Headlines

No Headlines